ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04064	NF-kappa B signaling pathway	7/64	96/7206	1.99766887165e-05
ko04217	Necroptosis	9/64	178/7206	2.39158540434e-05
ko00511	Other glycan degradation	4/64	26/7206	7.30615274245e-05
ko04622	RIG-I-like receptor signaling pathway	5/64	62/7206	0.000206680325483
ko04142	Lysosome	7/64	151/7206	0.000352623935422
ko04621	NOD-like receptor signaling pathway	7/64	157/7206	0.000446718920547
ko04668	TNF signaling pathway	6/64	120/7206	0.000641525967874
ko04210	Apoptosis	7/64	180/7206	0.00100891776628
ko04662	B cell receptor signaling pathway	5/64	88/7206	0.00104826999093
ko05146	Amoebiasis	5/64	99/7206	0.0017760087033
ko04620	Toll-like receptor signaling pathway	5/64	100/7206	0.00185683298082
ko05160	Hepatitis C	6/64	153/7206	0.0022570764119
ko01523	Antifolate resistance	3/64	30/7206	0.00228630952999
ko05161	Hepatitis B	6/64	173/7206	0.00415867015725
ko04660	T cell receptor signaling pathway	5/64	124/7206	0.00471911060783
ko05152	Tuberculosis	6/64	187/7206	0.00606495655181
ko04657	IL-17 signaling pathway	4/64	87/7206	0.00726206262312
ko00564	Glycerophospholipid metabolism	4/64	99/7206	0.011349644377
ko05215	Prostate cancer	4/64	111/7206	0.0166905065063
ko05221	Acute myeloid leukemia	3/64	63/7206	0.0181766964919
ko05167	Kaposi's sarcoma-associated herpesvirus infection	5/64	191/7206	0.0268158065103
ko00512	Mucin type O-glycan biosynthesis	2/64	29/7206	0.0270270078127
ko04380	Osteoclast differentiation	4/64	134/7206	0.0307944078025
ko05231	Choline metabolism in cancer	4/64	134/7206	0.0307944078025
ko05169	Epstein-Barr virus infection	5/64	206/7206	0.0355319122598
ko04024	cAMP signaling pathway	6/64	279/7206	0.0366283948922
ko05212	Pancreatic cancer	3/64	83/7206	0.0371374651003
ko00562	Inositol phosphate metabolism	3/64	89/7206	0.0442286498055
ko05222	Small cell lung cancer	3/64	89/7206	0.0442286498055